Comparison
11q Partial Monosomy Syndrome C0795841 vs 2 Hydroxyphenylacetic Aciduria C5937087
Clinical comparison between 11q Partial Monosomy Syndrome and 2 Hydroxyphenylacetic Aciduria for differential diagnosis and treatment planning.
11q Partial Monosomy Syndrome C0795841
A chromosomal disorder from missing genetic material on chromosome 11. It typically causes developmental delays, intellectual disability, and facial differences. Care focuses on symptom management and developmental interventions.
2 Hydroxyphenylacetic Aciduria C5937087
A rare metabolic disorder where the body cannot properly process certain acids. It may cause neurological issues and is typically identified in infancy. Management involves diet modifications and supportive care.
6 comparison axes
Onset
11q Partial Monosomy Syndrome C0795841
0-0
2 Hydroxyphenylacetic Aciduria C5937087
0-null
Onset patterns differ
Severity
11q Partial Monosomy Syndrome C0795841
severe
2 Hydroxyphenylacetic Aciduria C5937087
moderate
Different severity levels
Chronic
11q Partial Monosomy Syndrome C0795841
Chronic
2 Hydroxyphenylacetic Aciduria C5937087
Chronic
Differing course
Communicable
11q Partial Monosomy Syndrome C0795841
No
2 Hydroxyphenylacetic Aciduria C5937087
No
Different transmission
Body System
11q Partial Monosomy Syndrome C0795841
congenital
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Same/different system
Category
11q Partial Monosomy Syndrome C0795841
genetic
2 Hydroxyphenylacetic Aciduria C5937087
metabolic
Different category
Bottom line
11q-partial-monosomy-syndrome-C0795841 and 2-hydroxyphenylacetic-aciduria-C5937087 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 11q Partial Monosomy Syndrome C0795841 | 2 Hydroxyphenylacetic Aciduria C5937087 | Discriminating power |
|---|---|---|---|
| Developmental delay | Often described with developmental delay and intellectual disability from early life. | Neurological issues may occur, but a specific developmental pattern is not established. | Moderate |
| Facial differences | Facial differences are typically reported with the chromosomal condition. | Facial differences are not established from the supplied description. | Moderate |
| Metabolic features | No characteristic acid-processing abnormality is described. | Abnormal handling of certain acids may be identified, often in infancy. | High |
When to favor each condition
Choose 11q Partial Monosomy Syndrome C0795841 when
Congenital features with developmental concerns
A chromosomal cause is more consistent with missing chromosome 11 material and facial differences.
Moderate
Need to confirm a genetic structural diagnosis
Chromosomal testing can directly assess missing genetic material.
High
Severe lifelong congenital course
The supplied severity is severe and the category is genetic rather than primarily metabolic.
Moderate
Choose 2 Hydroxyphenylacetic Aciduria C5937087 when
Infancy with suspected metabolic abnormality
The condition is typically identified in infancy and involves acid processing.
Moderate
Neurological concerns without established chromosomal findings
A metabolic evaluation may be appropriate, but diagnosis is not established by symptoms alone.
Low
Diet-responsive metabolic management is being considered
Management may include dietary modification and supportive care after specialist confirmation.
Moderate
How key tests differ
| Test | 11q Partial Monosomy Syndrome C0795841 | 2 Hydroxyphenylacetic Aciduria C5937087 | Interpretation |
|---|---|---|---|
| Chromosomal microarray or karyotype | May show missing material involving chromosome 11. | Not expected to define this metabolic condition. | A chromosomal result supports the left diagnosis only when interpreted by a genetics clinician. |
| Urine organic acid analysis | No characteristic organic acid pattern is established here. | May show abnormal 2-hydroxyphenylacetic acid; exact cutoff is not supplied. | An abnormal result is not automatically a diagnosis and needs metabolic specialist review. |
| Developmental assessment | Often documents delay or intellectual disability. | May show neurological effects, but findings are not specific. | Assessment guides support needs but cannot distinguish the conditions alone. |
Prognosis comparison
11q Partial Monosomy Syndrome C0795841
- Outcome
- Often a severe chronic congenital condition, but individual outcome varies.
- Factors
- Extent of missing chromosome 11 material, associated anomalies, and developmental support may influence outcome.
2 Hydroxyphenylacetic Aciduria C5937087
- Outcome
- Described as moderate and chronic, but prognosis is not firmly established.
- Factors
- Age at recognition, neurological involvement, and response to dietary and supportive care may matter.
Time frame: Both may require long-term follow-up from infancy onward.
No reliable mortality or universal outcome can be stated from the supplied data.
Complications comparison
| Complication | Presentation |
|---|---|
| Neurodevelopmental impairment | Developmental delay and intellectual disability are typical concerns. Neurological issues may occur; severity is not fully established. Both may need developmental support, with individualized assessment. |
| Feeding or metabolic decompensation | Not established as a defining complication. Acid-processing difficulty may require dietary management. Specific triggers, thresholds, and emergency regimens are not supplied. |
| Associated congenital differences | Facial and other congenital differences may occur. Congenital anomalies are not established from the source. Additional findings require separate clinical evaluation. |
Patient education highlights
- HighDiagnosis requires confirmation
Symptoms or one abnormal test do not by themselves prove either condition. Ask a clinician to interpret genetic or metabolic results.
- HighSupportive care
Care is individualized and may include developmental interventions; the metabolic condition may also involve dietary changes.
- MediumFamily planning and inheritance
Genetic counseling may help for the chromosomal condition. Inheritance details for the metabolic condition are not established here.